Section 1. Policy. It is the policy of my Administration to coordinate a whole-of-government approach to advance biotechnology and biomanufacturing towards innovative solutions in health, climate change, energy, food security, agriculture, supply chain resilience, and national and economic security. Central to this policy and its outcomes are principles of equity, ethics, safety, and security that enable access to technologies, processes, and products in a manner that benefits all Americans and the global community and that maintains United States technological leadership and economic competitiveness.
Biotech health care innovations meet security challenges
Sec. 3. Harnessing Biotechnology and Biomanufacturing R&D to Further Societal Goals. (a) Within 180 days of the date of this order, the heads of agencies specified in subsections (a)(i)-(v) of this section shall submit the following reports on biotechnology and biomanufacturing to further societal goals related to health, climate change and energy, food and agricultural innovation, resilient supply chains, and cross-cutting scientific advances. The reports shall be submitted to the President through the APNSA, in coordination with the Director of the Office of Management and Budget (OMB), the APEP, the Assistant to the President for Domestic Policy (APDP), and the Director of OSTP.
(i) The Secretary of Health and Human Services (HHS), in consultation with the heads of appropriate agencies as determined by the Secretary, shall submit a report assessing how to use biotechnology and biomanufacturing to achieve medical breakthroughs, reduce the overall burden of disease, and improve health outcomes.
Sec. 8. Biotechnology Regulation Clarity and Efficiency. Advances in biotechnology are rapidly altering the product landscape. The complexity of the current regulatory system for biotechnology products can be confusing and create challenges for businesses to navigate. To improve the clarity and efficiency of the regulatory process for biotechnology products, and to enable products that further the societal goals identified in section 3 of this order, the Secretary of Agriculture, the Administrator of the Environmental Protection Agency, and the Commissioner of Food and Drugs, in coordination with the Director of OMB, the ADPD, and the Director of OSTP, shall:
The accelerator network began with eight accelerators located in regional hubs across the country where health security products and technologies in biotechnology, life science research, and medical innovations are heavily concentrated. These foundational accelerators are:
Technology drives healthcare more than any other force, and in the future it will continue to develop in dramatic ways. While we can glimpse and debate the details of future trends in healthcare, we need to be clear about the drivers so we can align with them and actively work to ensure the best outcomes for society as a whole.
Human nature does not change, at least not on these technological timescales. The authority structures in healthcare, the division of labour, the pretence that clinicians know everything, and other human factors are slow to change. Despite our knowledge of germ theory and antisepsis, we are still resistant to washing our hands.
This is the concern of User Centered Design (UCD), which Landauer describes well. The ideas have been taken up in international standards. In particular, healthcare technologies must be developed using UCD processes, such as ISO Standard 62366 etc.7 One of the most important features of the standards is that they make clear that new technologies are not going to be perfect and need to be tested and improved to better match how people actually use them.
Dedicated to healthcare industry innovation, we leverage decades of advanced technical, regulatory, and clinical expertise to help clients manage regulatory and global market access issues and address emerging connected device risks. We help to ensure that medical devices are safe to deploy for use in an increasingly patient-centric and connected environment and support clients in solving critical health, safety, security, and interoperability challenges.
Our complete portfolio of services includes combination product usability studies and packaging sterility, shelf life and transportation validation. We can assist you in your drive for excellence with learning development systems and training content trusted by the FDA for the healthcare and life sciences industry. We also offer potency and purity testing for OTC and pharmaceuticals, as well as pharmacopeial testing to U.S. and international standards.
We support you in your drive to deliver enhanced healthcare services. Our cybersecurity risk management solutions help protect Personal Health Information (PHI). Our occupational health and safety software, electronic medical records (EMR) and patient health software solutions empower you to keep employees safe and well, track workplace health and improve process efficiency.
Seventh, the E.O. launches a Biosafety and Biosecurity Innovation Initiative, to be helmed by the Secretary of HHS, that requires agencies funding, conducting, or sponsoring life sciences research to prioritize investments in applied biosafety research and innovations in biosecurity to reduce biological risk during the biotechnology R&D and biomanufacturing lifecycles, as well as incentivize and improve biosafety and biosecurity best practices. The E.O. requires the Secretary to report recommendations for accomplishing these objectives within 180 days, and agencies funding, conducting, or sponsoring this research to report on their efforts to accomplish these objectives within one year.
At the same time, the E.O. could result in more stringent regulatory requirements, particularly where necessary to address national security concerns and manufacturing risks. What is clear is that this is an area poised for significant future focus and expansion, and stakeholders across numerous industries, including healthcare, climate, agriculture, food, energy, and others would be well advised to keep abreast of developments and seek to provide input when opportunities to do so arise.
We prioritise personal wellbeing so that our people can thrive both in and out of work. We achieve this by fostering a healthy and safe working space for them to succeed and grow. Above all, working at GSK means working with colleagues, friends and managers who support, motivate and care for one another every step of the way.
Our work supports the health of all kinds of people. To meet our diverse patients' needs better, we need diversity in our clinical trials and to support our own people to thrive as part of an inclusive team.
Several telehealth tools are offered to help you manage your health care and receive the services you need. During the coronavirus disease 2019 (COVID-19) pandemic, many people used telehealth. People often still use it. Find out more about telehealth.
Telehealth is the use of digital information and communication technologies to access health care services remotely and manage your health care. Technologies can include computers and mobile devices, such as tablets and smartphones. This may be technology you use from home. Or a nurse or other health care professional may provide telehealth from a medical office or mobile van, such as in rural areas. Telehealth can also be technology that your health care provider uses to improve or support health care services.
Some clinics may use telemedicine to offer remote care. For example, clinics may offer virtual visits. These can allow you to see a health care provider, mental health counselor or a nurse via online video or phone chats.
Before your visit, your health care team may send you information or forms to fill out online and return to them. They may also make sure you have the technology you need. They'll check to see if you need to update or install any software or apps too. And they can tell you how to sign on and join the video chat for your visit. Also, the health care team can explain how to use the microphone, camera and text chat. If needed, ask a family member to help you set up the technology you need.
The primary care provider sends exam notes, history, test results, X-rays or other images to the specialist to review. The specialist may answer by email. Or they may do a virtual visit with you at your provider's office. They may also ask for a face-to-face meeting.
In some cases, a nurse or other health care professional may use technology to provide care from a medical office, clinic or mobile van in a rural area. They may call a specialist or provider at a medical clinic to do a remote consult.
Telehealth can be useful so you can stay home if you're sick or if it's hard for you to travel. And you can use telehealth if you live far from a medical center. And many people have been able to keep distance from others at home and still receive care during the COVID-19 pandemic. And providers can diagnose and treat COVID-19 remotely.
Telehealth has potential for better coordinated care. But it also runs the risk of gaps in care, overuse of medical care, inappropriate drug use or unnecessary care. Providers can't do a physical exam in-person, which can affect a diagnosis.
Also, some people who need improved access to care may be limited because of not having internet access or a mobile device. People without internet access may be able to access telehealth services by using wireless internet offered at public places. For example, libraries or community centers may offer wireless internet for virtual visits that can take place in private rooms.
When the production of food and fiber degrades the natural resource base, the ability of future generations to produce and flourish decreases. The decline of ancient civilizations in Mesopotamia, the Mediterranean region, Pre-Columbian southwest U.S. and Central America is believed to have been strongly influenced by natural resource degradation from non-sustainable farming and forestry practices. A sustainable agriculture approach seeks to utilize natural resources in such a way that they can regenerate their productive capacity, and also minimize harmful impacts on ecosystems beyond a field's edge. One way that farmers try to reach these goals is by considering how to capitalize on existing natural processes, or how to design their farming systems to incorporate crucial functions of natural ecosystems. By designing biologically-integrated agroecosystems that rely more on the internal cycling of nutrients and energy, it is often possible to maintain an economically viable production system with fewer potentially toxic interventions. For example, farmers aiming for a higher level of environmental sustainability might consider how they can reduce their use of toxic pesticides by bringing natural processes to bear on limiting pest populations. This might happen, for example, by planting hedgerows along field edges, or ground covers between rows, thereby providing habitat for insects and birds that prey on the pests, or by planting more diverse blends of crops that confuse or deflect pests (Figure 2). Maintaining a high degree of genetic diversity by conserving as many crop varieties and animal breeds as possible will also provide more genetic resources for breeding resistance to diseases and pests.Figure 2A clover and grass cover crop adds biodiversity to an almond orchard, which aids in nutrient cycling and provides habitat for beneficial insects, while also building soil organic matter. 2011 Nature Education Courtesy of Brodt et al. All rights reserved. Conservation of resources critical for agricultural productivity also means taking care of soil so that it maintains its integrity as a complex and highly structured entity composed of mineral particles, organic matter, air, water, and living organisms. Farmers interested in long-term sustainability often prioritize caring for the soil, because they recognize that a healthy soil promotes healthy crops and livestock. Maintaining soil functioning often means a focus on maintaining or even increasing soil organic matter. Soil organic matter functions as a crucial source and sink for nutrients, as a substrate for microbial activity, and as a buffer against fluctuations in acidity, water content, contaminants, etc. Furthermore, the buildup of soil organic matter can help mitigate the increase of atmospheric CO2 and therefore climate change. Another important function of soil organic matter is inducing a better soil structure, which leads to improved water penetration, less runoff, better drainage, and increased stability, thereby reducing wind and water erosion.Due to a high reliance on chemical fertilizers, agroecosystem functioning has been disconnected from the internal cycling of key plant nutrients such as nitrogen and phosphorus. Phosphate minerals for fertilizer are currently mined, but global reserves are predicted to sustain food production for only another 50 to 100 years. Consequently, phosphate prices are anticipated to rise unless new reserves are discovered and innovations in recovery of phosphates from waste are developed. The recycling of nitrogen and phosphorus (at the farm and regional scale), improving efficiencies of fertilizer applications, and relying on organic nutrient sources (animal and green manures) are important elements of sustainable agriculture (Figure 3). Recycling of nutrients is facilitated by a diversified agriculture in which livestock and crop production are more spatially integrated. For these reasons, extensive mixed crop-livestock systems, particularly in developing countries, could significantly contribute to future agricultural sustainability and global food security. 2ff7e9595c
Comments